Insulet (PODD) announced its revolutionary Omnipod 5 Automated Insulin Delivery System is now available in Australia and will soon be offered ...
Dexcom, the local maker of continuous glucose monitors, received a warning letter from the Food and Drug Administration last ...
The WHO estimates that 422 million people worldwide suffer from diabetes, with the majority residing in low- or middle-income ...
New research suggests that automated insulin delivery (AID) systems are safe and effective for use by older adults with type 1 diabetes. The findings counter common assumptions that older adults would ...
A recently published study highlighted the strong performance of the Insulet (Nasdaq:PODD) Omnipod 5 in children and young ...
The Omnipod 5 Automated Insulin Delivery System is now commercially available in Australia, launching soon in Belgium, Canada, and Switzerland. Insulet Corporation (NASDAQ: PODD) (Insulet or the Compa ...
Continuous Glucose Monitoring market poised for significant growth, driven by advancements in diabetes management and rising global prevalence.
This G6, from Chinese brand Xpeng, is the latest to launch – marking the start of the brand’s operations in the UK. We’ve already had a go in the new Xpeng G6 in Europe, but how does this ...